Eliglustat (Genz 112638) As Inhibitor Of Glucosylceramide Synthase For Use In A Method Of Treating Fabry'S Or Gaucher'S Disease, The Method Comprising Adjusting The Individual Therapeutical Dose To The P 450 Metabolism Of The Patient - EP3133070

PATENT ANALYSIS

Patent Details

More patents of Genzyme Corporation

Want to monitor this patent?

Feel free to send us a message here and we will get back to you